share_log

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities-Director Arduini Peter J

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities-Director Arduini Peter J

施貴寶 | 4：持股變動聲明-董事 Arduini Peter J
SEC announcement ·  04/02 18:41
Moomoo AI 已提取核心訊息
Peter J Arduini, a reporting person for Bristol-Myers Squibb (BMY), has engaged in a transaction involving the company's stock. The action took place on March 31, 2024. However, the specific details regarding the nature of the transaction, such as the number of shares involved, the transaction price, and the resulting ownership stake, have not been disclosed. This information is critical for investors to understand the implications of the transaction on their investment decisions.
Peter J Arduini, a reporting person for Bristol-Myers Squibb (BMY), has engaged in a transaction involving the company's stock. The action took place on March 31, 2024. However, the specific details regarding the nature of the transaction, such as the number of shares involved, the transaction price, and the resulting ownership stake, have not been disclosed. This information is critical for investors to understand the implications of the transaction on their investment decisions.
百時美施貴寶（BMY）的舉報人彼得·阿杜尼參與了一項涉及該公司股票的交易。該行動於 2024 年 3 月 31 日進行。但是，有關交易性質的具體細節，例如所涉及的股票數量、交易價格以及由此產生的所有權，尚未披露。這些信息對於投資者了解交易對其投資決策的影響至關重要。
百時美施貴寶（BMY）的舉報人彼得·阿杜尼參與了一項涉及該公司股票的交易。該行動於 2024 年 3 月 31 日進行。但是，有關交易性質的具體細節，例如所涉及的股票數量、交易價格以及由此產生的所有權，尚未披露。這些信息對於投資者了解交易對其投資決策的影響至關重要。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息